Abstract: Preactivated and disaggregated shape-changed platelets, fixed shape-changed platelets, and a pharmaceutical composition thereof are used for treating acute and emergent inflammatory disease in a dosage of 1×106 to 1×108. SC-PLT is a disaggregated and activated platelet, the secretome from platelet activation has been deprived after SC-PLT preparation but their membrane still preserve cell adhesion molecular and integrin glycoprotein (eg. P-selectin, GP1a, and GPIIb etc.). Therefore, SC-PLTs can trap stromal vascularity inflammatory cells from inflammated and damaged place, and the stromal vascularity inflammatory cells are eliminated through the circulatory system to alleviate inflammation. The fixed shape-changed platelets are able to alleviate inflammation and sustainable for longer storage duration.

Abstract: Apparatuses and methods for inspecting a section of piping are disclosed. In one example embodiment, an apparatus includes first and second excitation coils, a plurality of magnetometers, and a data acquisition system. The first excitation coils are disposed at a first axial location and are energized and the second excitation coils are disposed at a second axial location and are energized. The plurality of magnetometers are disposed at an axial location between the first and second axial locations and are positioned to detect magnetic fields generated by eddy currents induced in the section of piping by the first and second excitation coils. The data acquisition system is operatively connected to receive output data from the plurality of magnetometers.

Abstract: A method is provided for manufacturing ophthalmically-acceptable, distortion-free silicone hydrogel contact lenses without the use of volatile organic solvents in the manufacturing process. The contact lenses are extract with an extraction liquid comprising an aqueous solution of a non-volatile organic solvent, such as ethyl lactate.

Abstract: Preactivated and disaggregated shape-changed platelets, fixed shape-changed platelets, and a pharmaceutical composition thereof are used for treating acute and emergent inflammatory disease in a dosage of 1×106 to 1×108. Activated platelets release and transfer adhesion factors to the surface of platelet cells, and trap stromal vascularity inflammatory cells from inflammated and damaged place, and the stromal vascularity inflammatory cells are eliminated through the circulatory system to alleviate inflammation. The fixed shape-changed platelets are able to alleviate inflammation and sustainable for longer storage duration.

Abstract: A method for obtaining a three-phase power flow of a power distribution network and a device for obtaining a three-phase power flow of a power distribution network are provided. The method comprises steps of: selecting a three-phase power transformer with an ungrounded neutral connection in the power distribution network; correcting a three-phase admittance matrix of the three-phase power transformer; and applying the three-phase admittance matrix to a preset algorithm to obtain a three-phase power flow of the power distribution network.

Abstract: Preactivated and disaggregated shape-changed platelets, fixed shape-changed platelets, and a pharmaceutical composition thereof are used for treating acute and emergent inflammatory disease in a dosage of 1×106 to 1×108. Activated platelets release and transfer adhesion factors to the surface of platelet cells, and trap stromal vascularity inflammatory cells from inflammated and damaged place, and the stromal vascularity inflammatory cells are eliminated through the circulatory system to alleviate inflammation. The fixed shape-changed platelets are able to alleviate inflammation and sustainable for longer storage duration.

Abstract: Silicone hydrogel contact lenses, when hydrated, have a plurality of depressions on one or more of the lens surfaces. The depressions have a depth less than 1 micrometer, or less than 100 nanometers. The silicone hydrogel contact lenses have not been subject to treatment with plasma. Methods of manufacturing the silicone hydrogel contact lenses are also disclosed.

Abstract: The present invention provides resveratrol-based boron-containing analog! methods of use thereof in treatment of dyslipidemias and cancer.

Abstract: A display method and apparatus are disclosed. The method includes: when a video layer needs to scale a video image, judging whether a preset policy is met; if so, using the offline mode; otherwise using the online mode; processing the video image in online mode or offline mode, and outputting the processed video image, where the online mode is a mode in which the video image frame is scaled in real time, and the offline mode is a mode in which the video image frame is scaled asynchronously. With the display method and apparatus, the source video image can be scaled in any ratio by selecting the online mode or offline mode, thus reducing the display power consumption.

Abstract: Silicone hydrogel contact lenses, when hydrated, have a plurality of depressions on one or more of the lens surfaces. The depressions have a depth less than 1 micrometer, or less than 100 nanometers. The silicone hydrogel contact lenses have not been subject to treatment with plasma. Methods of manufacturing the silicone hydrogel contact lenses are also disclosed.

Abstract: A display method and apparatus are disclosed. The method includes: when a video layer needs to scale a video image, judging whether a preset policy is met; if so, using the offline mode; otherwise using the online mode; processing the video image in online mode or offline mode, and outputting the processed video image, where the online mode is a mode in which the video image frame is scaled in real time, and the offline mode is a mode in which the video image frame is scaled asynchronously. With the display method and apparatus, the source video image can be scaled in any ratio by selecting the online mode or offline mode, thus reducing the display power consumption.

Abstract: Isolated PNMT nucleic acid molecules that include a nucleotide sequence variant and nucleotides flanking the sequence variant are described, as well as PNMT allozymes. Methods for determining if a subject is predisposed to multiple sclerosis, early-onset Alzheimer's disease, or Parkinson's disease also are described.

Abstract: Isolated PNMT nucleic acid molecules that include a nucleotide sequence variant and nucleotides flanking the sequence variant are described, as well as PNMT allozymes. Methods for determining if a subject is predisposed to multiple sclerosis, early-onset Alzheimer's disease, or Parkinson's disease also are described.